Women's Cancer Center - Los Gatos Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
1998
NCT00003382
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

cisplatin (platinol) (1 trial)

paclitaxel (taxol) (1 trial)

Drugs in Phase 1 Trials (3)

gemcitabine (gemzar) (1 trial)

sargramostim (leukine) (1 trial)

topotecan (hycamtin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 1)

Fallopian Tube Neoplasms (Phase 1)

Ovarian Neoplasms (Phase 1)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5